DEPARTMENT OF JUSTICE

Cubist Pharma Shares Hit New High

IBTimes Logo
Shares of Cubist Pharmaceuticals Inc. (CBST) touched a new 52-week high of $30.02 on Wednesday morning. Optimer Pharmaceuticals Inc. (OPTR) said it has entered an exclusive two-year co-promotion agreement with Cubist to market Dificid in the U.S.
More news
7. Michigan

Foreclosure deal slowed by infighting: sources

U.S. regulators' efforts to settle with banks over improper mortgage foreclosures are being hampered by infighting among the groups involved in the talks, and a settlement may take a while, according to sources familiar with the matter.

U.S. yet to decide if Google should rule online travel

The approval for Google’s acquisition of ITA Software for $700 million is still pending from the U.S. Justice Department, as it is considering if the deal will give Google influence over the entire online flight industry.
Daniel Patrick Boyd is escorted into the Wake County Public Safety Center after appearing at a detention hearing at the Terry Sanford Federal Building and Courthouse in Raleigh North Carolina August 4, 2009.

North Carolina man trained in Pak pleads guilty to 'jihad' charges

Daniel Patrick Boyd, a U.S. citizen and resident of North Carolina, has pleaded guilty in a federal court to charges of conspiracy to provide material support to terrorists and conspiracy to murder, kidnap, maim, and injure persons in a foreign country, the U.S. Department of Justice (DOJ) said.
Fast, Fresh Food is Winning

U.S. fast food caught in immigration crosshairs

Chipotle Mexican Grill (CMG.N) has a lot going for it -- an upscale burrito concept, a hip and eco-friendly image, expansion plans galore and a 500 percent-plus stock price gain in just over two years.
IBTimes Logo

Superbowl a magnet for under-age sex trade

Pimps will traffic thousands of under-age prostitutes to Texas for Sunday's Super Bowl, hoping to do business with men arriving for the big game with money to burn, child rights advocates said.
IBTimes Logo

Mylan, Pfizer settle patent disputes over Lipitor, Caduet

U.S. generic drug maker Mylan Inc has settled two U.S. patent disputes with global pharma giant Pfizer Inc, which will enable the former to sell the generic versions of cholesterol drug Lipitor and combination blood pressure and cholesterol treatment Caduet.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.